Clinical trial
Dutasteride to Treat Women With Menstrually Related Mood Disorders
NCT00082043 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00082043 |
|---|---|
| Title | Dutasteride to Treat Women With Menstrually Related Mood Disorders |
| Official title | The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women With Menstrual-Related Mood Disorders and Controls |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Premenstrual Syndrome, PMS, Healthy, Depression |
| Intervention type | Drug |
| Interventions | Dutasteride, Placebo oral capsule |
| Enrollment | 34 |
| Start date | Mar 31, 2004 |
| Primary completion | Mar 6, 2014 |
| Completion | Mar 6, 2014 |
| First posted | Apr 28, 2004 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: